A prospective study to examine the effectiveness and safety of neuraminidase inhibitors in index cases with presumed pandemic influenza infectio

Not Applicable

• Conditions: Pandemic influenza; Infection - Other infectious diseases

• Registration Number: ACTRN12608000176369
• Lead Sponsor: ational Centre in HIV Epidemiology and Clinical Research (NCHECR)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-04-09
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

1. Clinical diagnosis of pandemic influenza (consistent with the applicable clinical case definition)
2. Provision of written informed consent or equivalent
3. Intention to commence treatment with a neuraminidase inhibitor

Exclusion Criteria

There are no exclusion criteria.

Study & Design

• Study Type: Observational
• Study Design: Not specified